You are on page 1of 16
Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America Julia Wijkström, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3 Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2 Magnus Söderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and Annika Wernerson, MD, PhD1,5 2013 Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4 Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7 Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´ n, MD, PhD,2 Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7 2016 Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4 Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7 Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´ n, MD, PhD,2 Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7 2016 Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4 Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7 Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´ n, MD, PhD,2 Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7 2016 Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4 Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7 Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´ n, MD, PhD,2 Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7 2016 Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4 Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7 Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´ n, MD, PhD,2 Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7 2016 Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4 Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7 Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´ n, MD, PhD,2 Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7 2016 Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4 Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7 Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´ n, MD, PhD,2 Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7 2016